Dangane da yanayin saurin bunƙasa fasahar likitanci ta duniya, yana da mahimmanci a fahimci haɓakar haɓakawa da sabbin samfuran manyan kamfanoni na masana'antu.A baya can, jerin sunayen da suka fi tasiri a ketare (Medtech Big 100, Top 100 Medical Devices, Medical Devices 25, da dai sauransu) ba su sanya kamfanonin kasar Sin gaba daya cikin kididdigar su ba.Don haka, Siyu MedTech ya haɓaka jerin Global MedTech TOP 100 dangane da rahoton kuɗi na 2022 na kamfanoni da aka jera a yankuna daban-daban da za a fito da su a cikin 2023.
.
Wannan jeri na musamman ne kuma na kimiyya domin ya haɗa da mafi kyawun kamfanonin na'urorin likitanci a duk duniya:
Haɗin da aka jera sunayen kamfanonin na'urorin likitanci na kasar Sin yana ba da cikakken hoto game da matsayi da tasirin Sin a masana'antar na'urorin likitancin duniya.
Tushen bayanai da hanyar lissafin jeri: An ƙididdige shi dangane da kudaden shiga a cikin kuɗin kuɗi na 2022 da kowane kamfani ya fitar kafin 30 Oktoba 2023 Ga wasu manyan ƙungiyoyin haɗin gwiwar, kudaden shiga na shekara-shekara na sashin na'urar likitanci na kasuwanci ne kawai ake ƙididdige su;An tabbatar da cikakken gaskiya da amincin bayanan.(Saboda buƙatun daban-daban na kamfanonin da aka jera a yankuna daban-daban, lokacin kasafin kuɗi ba ɗaya bane, saboda waɗannan kudaden shiga sun dace daidai da daidai lokacin.)
Don ma'anar na'urorin likitanci, an dogara ne akan ka'idojin kasar Sin game da sa ido da sarrafa na'urorin likitanci.
Bayani na musamman: Kamfanonin Sin da ke cikin wannan jerin sun hada da:
Myriad Medical (33rd), JiuAn Medical (40th), Weigao Group (61st), Daan Genetics (64th), Lepu Medical (66th), Mind Bio (67th), Union Medical (72nd), Oriental Biotech (73rd), Stable Medical (81st), Yuyue Medical (82nd), Kewa Biotech (84th), Xinhua Medical (85th), Inventec Medical (87th), Shengxiang Biotechnology (89th), Guoke Hengtai (90th), Anxu Biotechnology (91st), Wicresoft Medical (92nd) ), Zhende Medical (93rd), Wanfu Biotechnology (95th), Kepu Biotechnology (96th), Shuoshi Biotechnology (97th), da Lanshan Medical (100th).
Dangane da 2023 Global MedTech TOP100, kamfanonin na'urorin likitanci suna da halaye masu zuwa:
Rarraba kudaden shiga yana da rashin daidaituwa: 10% na kamfanonin da ke cikin jerin suna da kudaden shiga sama da dala biliyan 100, 54% suna ƙasa da dala biliyan 10, kuma 75% suna ƙasa da dala biliyan 40, suna nuna cikakkiyar halayen masana'antar na'urorin likitanci.
Tasirin gungu na yanki sun bayyana a fili:
Kasar Amurka tana da kashi 40 cikin 100 na kamfanonin da ke cikin jerin;balaga na kasuwar MedTech ta, ƙarfin sa don ƙirƙira fasaha, da kuma karɓar sabbin samfuransa suna ba da gudummawa ga ingantaccen yanayin ƙirƙira.
Kasar Sin na biye da kashi 17 cikin 100 na helkwatar kamfanoni;tana amfana daga tallafin manufofin ƙasar, karuwar buƙatun kasuwa, da ƙarfin samarwa da sarkar samarwa.
Babban bayanin kula shine Switzerland da Denmark, ƙananan ƙasashe biyu waɗanda ke da kamfanoni huɗu kowannensu waɗanda suka ƙware sosai kuma suna fafatawa a cikin takamaiman sassan kasuwa.
Lokacin aikawa: Dec-18-2023